Medically reviewed by ChinaCureLink Team
Table of Content
Introduction
When stomach cancer comes back, families often start searching for something beyond the treatments they have already tried. If chemotherapy, surgery, immunotherapy or targeted treatment has stopped controlling the disease, the words “clinical trial” can offer another avenue to investigate.
Finding a suitable trial, however, is not as simple as searching Google for “stomach cancer clinical trials in China.” Trials are designed for specific groups of patients, and a study that looks promising may still be unsuitable because of a patient's previous treatments, tumor biomarkers or current condition.
China is an important country to investigate because its major cancer centers are actively involved in clinical research. The Chinese Clinical Trial Registry (ChiCTR), which is part of the WHO International Clinical Trials Registry Platform, provides a searchable database of studies conducted in China.
Key Takeaways |
|
Why Consider Clinical Trials in China for Recurrent Stomach cancer?
Clinical research in gastric cancer is expanding in several areas, including targeted therapy, immunotherapy and cellular therapies.
One particularly active area is CLDN18.2-targeted treatment. Researchers are investigating different ways to target CLDN18.2, including antibody-based therapies, antibody-drug conjugates, bispecific antibodies and CAR-T therapies.
This is relevant because CLDN18.2 is found on many gastric cancer cells and has become an important target in the development of new treatments.
China has also been involved in clinical research evaluating CLDN18.2-directed CAR-T therapy. In a study of satricabtagene autoleucel (satri-cel/CT041), a CLDN18.2-targeted CAR-T therapy, researchers reported an overall response rate of 38.8% among 98 patients with CLDN18.2-positive advanced gastrointestinal cancers.
These results do not mean CAR-T is appropriate for every patient with recurrent stomach cancer. They show why biomarker testing and careful trial matching matter.
Where Can I Search for Stomach Cancer Trials in China?
1. Chinese Clinical Trial Registry (ChiCTR)
The Chinese Clinical Trial Registry is one of the most useful starting points for finding clinical studies conducted in China.
The registry allows searches using information such as:
Disease
Intervention
Hospital
Province or city
Study type
Study phase
Recruitment status
Registration number
Study sponsor
The database also contains historical and current trial records, so patients should pay close attention to the recruitment status rather than assuming that every listed study is still accepting participants.
ClinicalTrials.gov is another useful resource, particularly for multinational studies.
The NCI's current stomach-cancer trial listings include studies involving advanced, unresectable or metastatic gastric and gastroesophageal-junction cancers, as well as studies investigating newer drugs and treatment combinations.
When searching, use terms such as:
“gastric cancer,” “stomach cancer,” “advanced gastric cancer,” “recurrent gastric cancer,” “CLDN18.2,” “CAR-T,” and “China.”
It can also help to search by the specific biomarker or treatment target rather than simply using “stomach cancer.”
What Information Do I Need Before Searching?
A clinical-trial search becomes much more useful when you have your medical information organized.
Try to have:
Pathology report
Original diagnosis and stage
Current scans
Previous scan results
Surgery records
Chemotherapy history
Immunotherapy history
Targeted-treatment history
Current medications
Biomarker results
Current disease status
Basic blood-test results
Biomarker information can be particularly important.
Ask your oncology team whether testing has been performed for HER2, PD-L1, MSI/MMR and CLDN18.2, where medically appropriate.
For example, searching for a CLDN18.2-targeted clinical trial is unlikely to be useful if you do not know whether your tumor expresses CLDN18.2.
How Do I know Whether a Clinical Trial is Actually Relevant?
Finding a trial is only the first step.
Every clinical trial has inclusion and exclusion criteria. These can be surprisingly specific.
A study may require:
A particular cancer type
A specific stage
Measurable disease on imaging
A particular biomarker
A minimum or maximum number of previous treatments
Progression after a particular therapy
Adequate kidney, liver or blood-cell function
A specific age range
A particular performance status
For recurrent stomach cancer, previous treatment history is especially important.
For example, a trial designed for patients whose cancer has progressed after two previous treatment lines may not accept someone who has received only one line. Conversely, another trial may specifically require patients who have already received several therapies.
This is why a trial that appears suitable from its title may not actually be an option.
What Should I Check Before Contacting a Chinese Hospital?
Before making an international trip, verify several basic details.
Is the Trial Recruiting?
A trial may appear in a registry even when recruitment has finished, been suspended or has not yet started.
Always confirm the current status directly with the study site.
Where is the Trial Being Conducted?
China has major cancer centers in cities including Beijing, Shanghai, Guangzhou, Shenzhen and other regions. The registry should identify the participating institution or study site.
Is the Treatment Approved or Investigational?
This distinction matters.
An approved therapy and an experimental treatment being studied in a clinical trial should never be presented as the same thing.
Are International Patients Accepted?
Not every clinical trial is automatically open to patients travelling from overseas. The hospital should confirm whether foreign patients can be screened and enrolled.
What Costs are Covered?
Ask whether the study covers the investigational treatment, tests and hospital visits. You should also ask about expenses that may remain your responsibility, including travel, accommodation, supportive medications or follow-up care.
Can ChinaCureLink Help Me Find a Clinical Trial?
For an international patient, one of the biggest challenges is often not finding a trial listing but determining which trial is worth pursuing.
ChinaCureLink can help organize a medical-record package and coordinate with Chinese hospitals for case evaluation.
This can be particularly useful when you are considering advanced treatments such as targeted therapy, immunotherapy or cellular therapy.
The process can involve reviewing your pathology, imaging, previous treatment history and biomarker results before approaching an appropriate hospital or treatment program.
The goal is not to promise enrollment. Instead, the purpose is to determine whether your medical profile may fit a particular treatment pathway and what additional information the hospital requires.
What Questions Should I Ask About a China Clinical Trial?
Before agreeing to participate, ask:
What is the exact name and registration number of the trial?
What phase is the trial?
Is recruitment currently open?
What hospital and physician are responsible for the study?
What biomarker or medical criteria are required?
How many previous treatments are allowed or required?
What are the known risks and side effects?
What costs are covered by the study?
How long would I need to remain in China?
What follow-up is required after returning home?
A reputable hospital or trial team should be able to explain these points clearly.
What If I Cannot Find a Suitable Clinical Trials For Recurring Stomach Cancer Myself?
You do not necessarily need to search every registry manually.
A specialist oncology team can sometimes identify relevant studies based on the patient's diagnosis, biomarkers and treatment history.
The NCI explains that clinical trials can provide access to treatments being studied for cancer, and its trial-search system allows patients to filter studies by cancer type, treatment and location.
For international patients considering China, the same principle applies: start with the medical profile, then search for the trial.
This is usually more productive than starting with a treatment name that you found online.
How ChinaCureLink Can Help International Patients Explore Clinical Trials in China
ChinaCureLink helps international patients explore clinical trials for recurring stomach cancer at hospitals in China.
For recurrent stomach cancer, the process can begin with reviewing your medical records, pathology, imaging and previous treatment history. Where relevant, biomarker information such as HER2, PD-L1, MSI/MMR and CLDN18.2 can help determine which treatment pathways may warrant further investigation.
ChinaCureLink can then help coordinate communication with appropriate Chinese hospitals and assist with the practical process of international treatment planning.
A clinical trial is never guaranteed, and final eligibility must be determined by the treating hospital and study investigators.
For a family facing recurrent stomach cancer, however, understanding what trials exist, whether they are recruiting, and whether the patient's cancer characteristics match the protocol can be an important part of understanding the options available.
Get a Second Opinion Before Fly to China
For suitable cases, ChinaCureLink can then coordinate an online consultation with the specialist to discuss the technical treatment details directly. The purpose is to help the patient understand which treatment option and which specialist center may be most appropriate before making an international treatment decision.
What Patients Say About ChinaCureLink & Medebound HEALTH
China CureLink operates under Medebound HEALTH — an internationally recognized healthcare navigation company incorporated in New York, with operations across North America and Asia-Pacific.
Rated 4.6 ⭐⭐⭐⭐⭐ at Trustpilot
Medebound HEALTH's online testimonials. Learn More
Frequently Asked Questions
Are There Clinical Trials for Recurrent Stomach Cancer in China?
Yes. Chinese hospitals conduct clinical research involving gastric cancer, including studies of targeted therapies, immunotherapy and cellular therapies. Current recruitment must be confirmed with the individual trial site.
How Can I find Gastric Cancer Clinical Trials in China?
Start with the Chinese Clinical Trial Registry (ChiCTR) and ClinicalTrials.gov. Search using terms such as gastric cancer, recurrent gastric cancer, CLDN18.2 and CAR-T, then check the trial's recruitment status and eligibility criteria.
Can International Patients Join Clinical Trials in China?
Some Chinese hospitals may evaluate international patients, but eligibility and enrollment depend on the individual study and hospital. International patients should confirm this directly with the study site before travelling.
What Biomarkers are Important for Stomach Cancer Trials?
Depending on the trial, biomarkers such as HER2, PD-L1, MSI/MMR and CLDN18.2 may be important. The required biomarker depends on the treatment being investigated.
Is CAR-T Being Studied for Stomach Cancer in China?
Yes. CLDN18.2-targeted CAR-T therapies have been studied in patients with advanced gastrointestinal cancers, including gastric cancer. Published studies have reported clinical responses, but these therapies are intended for selected patients and can carry significant risks.
About ChinaCureLink
ChinaCureLink helps patients across the world access the best cancer treatment at China's top hospitals, without the delays, language barriers, and administrative confusion that typically come with seeking care abroad.
We connect patients directly with China's top cancer hospitals, ensuring that from the first case submission through to treatment and follow-up, every step is guided, translated, and coordinated by a team experienced in cross-border patient care.
ChinaCureLink is proudly affiliated with Medebound HEALTH — founded by US physicians, with over 10 years of experience and more than 3,000 patients served worldwide, Medebound HEALTH is recognized by Forbes and it is one of the most trusted patient cross-border concierge service company across North America and the Asia Pacific.
Disclaimer
This article is for informational purposes only and is not medical or financial advice. Treatment eligibility, protocols, and costs vary by individual case — confirm specifics with a coordinator and treating physician before making any decisions.
References
Chinese Clinical Trial Registry (ChiCTR) — WHO Primary Registry.
National Cancer Institute — Gastric (Stomach) Cancer Clinical Trials. NCI Clinical Trials
National Cancer Institute — Treatment of Stomach Cancer. NCI Stomach Cancer Treatment
Qi C, et al. CLDN18.2-specific CAR T cells in gastrointestinal cancers. Nature Medicine. 2024. PubMed
Gastric cancer clinical-trial landscape and CLDN18.2 research. 2026 review. PubMed